Assessing the Validity of a a priori Patient-Trial Generalizability Score using Real-world Data from a Large Clinical Data Research Network: A Colorectal Cancer Clinical Trial

by   Qian Li, et al.

Existing trials had not taken enough consideration of their population representativeness, which can lower the effectiveness when the treatment is applied in real-world clinical practice. We analyzed the eligibility criteria of Bevacizumab colorectal cancer treatment trials, assessed their a priori generalizability, and examined how it affects patient outcomes when applied in real-world clinical settings. To do so, we extracted patient-level data from a large collection of electronic health records (EHRs) from the OneFlorida consortium. We built a zero-inflated negative binomial model using a composite patient-trial generalizability (cPTG) score to predict patients clinical outcomes (i.e., number of serious adverse events, (SAEs)). Our study results provide a body of evidence that 1) the cPTG scores can predict patient outcomes; and 2) patients who are more similar to the study population in the trials that were used to develop the treatment will have a significantly lower possibility to experience serious adverse events.



There are no comments yet.


page 1


Combining Real-World and Randomized Control Trial Data Using Data-Adaptive Weighting via the On-Trial Score

Clinical trials with a hybrid control arm (a control arm constructed fro...

In-silico Risk Analysis of Personalized Artificial Pancreas Controllers via Rare-event Simulation

Modern treatments for Type 1 diabetes (T1D) use devices known as artific...

Intelligent Sight and Sound: A Chronic Cancer Pain Dataset

Cancer patients experience high rates of chronic pain throughout the tre...

Using routinely collected patient data to support clinical trials research in accountable care organizations

Background: More than half (57 support of clinical trials. One reason is...

Metrics to find a surrogate endpoint of OS in metastatic oncology trials: a simulation study

Surrogate endpoint (SE) for overall survival (OS) in cancer patients is ...

Doctor2Vec: Dynamic Doctor Representation Learning for Clinical Trial Recruitment

Massive electronic health records (EHRs) enable the success of learning ...
This week in AI

Get the week's most popular data science and artificial intelligence research sent straight to your inbox every Saturday.